Magnetar Financial LLC 13D and 13G filings for Ibere Pharmaceuticals:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-02 11:10 am Sale |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Magnetar Financial LLC | 785,872 5.690% |
-7,419 (-0.94%) |
Filing |
| 2022-01-14 1:43 pm Purchase |
2021-12-31 | 13G | Ibere Pharmaceuticals IBER |
Magnetar Financial LLC | 793,291 5.750% |
793,291 (New Position) |
Filing |